U.S. Phase 2a Clinical Trial in Recurrent Glioblastoma to Initiate in Early 2015 Australian Phase 0/1 Clinical Trial in Mesothelioma to Initiate in Third Quarter of 2014 Additional Studies Planned for Non-Small Cell Lung Cancer /PRNewswire/ — EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer … (more)
Source: www.topix.com Via newsmixx: home News